 |
|
Increasing survival of organ transplant patients by reducing time interval for transported organs
April 27, 2007Preservation of an organ intended for transplant during transport from donor to recipient is of primary concern in ensuring a successful transplant. Research presented at the ISHLT 27th Annual Meeting and Scientific Sessions today explores two diverging systems for pump preservation - the Organ Care System (OCS) and the cold preservation method, and how they each effect survival for heart transplant patients.
The cold preservation method, which has been in practice for more than 25 years, delivers the organ in a non-functioning state immersed in a cold solution for preservation during transport. The time during transport in this method is referred to as cold ischemic time (CIT), more specifically the interval beginning when an organ is removed from the donor and is cooled with the solution, to the time when the organ is implanted.
Conversely, the Organ Care System (OCS) is based on warm blood perfusion technology, which it uses to maintain organs in a warm, functioning state. This state mimics the environment of the human body during transport from organ donor to recipient. Nutrient rich, oxygenated blood is continuously pumped through the heart in order to maintain the organ in a living, beating, state. Preserving an organ with this method reduces CIT and allows for evaluation of organ function during transport.
New data presented during a late afternoon session on Wednesday, Concurrent Session 2 Cardiac Ischemic Time: Warm, Cold, or Pump?, highlighted the benefits of reducing or eliminating CIT, such as increased availability of donor organs, improved transplant outcomes, and reduced costs associated with end stage organ failure. Presentations during the session outlined research results demonstrating that reducing CIT will increase survivorship, and further how the OCS may eliminate CIT almost entirely.
Gero Tenderich, M.D., Clinic for Thoracic and Cardiovascular Medicine, Bad Oeynhausen, Germany, provided results from the PROTECT I clinical trial, Prospective Multi-Center European Trial To Evaluate the Safety and Performance of the Organ Care System for Heart Transplants, during the Wednesday session (Abstract 10). The PROTECT I trial, which was performed in Europe, studied the efficacy of the OCS in regards to survivorship. The results demonstrate the use of the OCS in maintaining and transporting donated hearts for transplant surgery. Results showed 100 percent survival of patients 30 days post surgery. Results also revealed that using the OCS allowed for patients to spend less time on the ventilator and experience a quicker recovery in the hospital. The ability of the OCS to assess organ function was also discussed. The trial sites participating in the PROTECT I study included the Clinic for Thoracic and Cardiovascular Medicine, Bad Oeynhausen and the German Heart Institute in Berlin, Germany, as well as Papworth Hospital and Harefield Hospitals, NHS Trusts in Cambridge and Middlesex, United Kingdom, respectively.
The U.S. Food and Drug Administration has recently granted IDE approval to initiate the pilot phase of the PROCEED multi-center clinical trial in the U.S. to evaluate the safety and performance of the OCS for heart transplants. The PROCEED trials will take place at five centers, including University of Pittsburgh Medical Center in Pittsburgh; Heart, Lung, and Esophageal Surgery Institute in Pittsburgh; UCLA Medical Center in Los Angeles; The Cleveland Clinic Heart and Vascular Institute in Cleveland, The University of Chicago Hospitals Cardiac Center in Chicago and Brigham & Women's Hospital in Boston.
"The PROTECT trial results establish validity of the Organ Care System. Given its relatively recent introduction to the transplant world, we are excited about the results and look forward to seeing what further tests will demonstrate about this innovative system," said Bruce Rosengard, M.D., Director of Cardiac Transplantation at Massachusetts General Hospital and former ISHLT board member.
Analysis of data from studies conducted in the United Kingdom and Australia were presented by Julian Gooi, M.D., Alfred Hospital, Melbourne, Australia, The Potential Impact of Reducing Cold Ischaemic Time on Cardiac Transplant Survival (Abstract 8) during the same Concurrent Session. The analysis concluded that a CIT of less than one hour would result in longer-term survival or an increase in life-years gained (LYG). Overall, the research showed that there were 2.2 LYG per donor heart for the United Kingdom transplant program, and 2.1 LYG per donor heart for the Australian transplant program. Dr. Gooi's presentation demonstrated how reworking the means of transport and developing central procurement and transplant centers could be beneficial to the transplant community.
"These results should alert the transplant community of issues that need immediate attention in order to increase survivorship in transplant patients. The amount of life years gained through better efficiency within the organ transport system is astonishing," continued Dr. Rosengard.
International Society for Heart and Lung Transplantation
New data presented during a late afternoon session on Wednesday, Concurrent Session 2 Cardiac Ischemic Time: Warm, Cold, or Pump?, highlighted the benefits of reducing or eliminating CIT, such as increased availability of donor organs, improved transplant outcomes, and reduced costs associated with end stage organ failure. Presentations during the session outlined research results demonstrating that reducing CIT will increase survivorship, and further how the OCS may eliminate CIT almost entirely.
Gero Tenderich, M.D., Clinic for Thoracic and Cardiovascular Medicine, Bad Oeynhausen, Germany, provided results from the PROTECT I clinical trial, Prospective Multi-Center European Trial To Evaluate the Safety and Performance of the Organ Care System for Heart Transplants, during the Wednesday session (Abstract 10). The PROTECT I trial, which was performed in Europe, studied the efficacy of the OCS in regards to survivorship. The results demonstrate the use of the OCS in maintaining and transporting donated hearts for transplant surgery. Results showed 100 percent survival of patients 30 days post surgery. Results also revealed that using the OCS allowed for patients to spend less time on the ventilator and experience a quicker recovery in the hospital. The ability of the OCS to assess organ function was also discussed. The trial sites participating in the PROTECT I study included the Clinic for Thoracic and Cardiovascular Medicine, Bad Oeynhausen and the German Heart Institute in Berlin, Germany, as well as Papworth Hospital and Harefield Hospitals, NHS Trusts in Cambridge and Middlesex, United Kingdom, respectively.
The U.S. Food and Drug Administration has recently granted IDE approval to initiate the pilot phase of the PROCEED multi-center clinical trial in the U.S. to evaluate the safety and performance of the OCS for heart transplants. The PROCEED trials will take place at five centers, including University of Pittsburgh Medical Center in Pittsburgh; Heart, Lung, and Esophageal Surgery Institute in Pittsburgh; UCLA Medical Center in Los Angeles; The Cleveland Clinic Heart and Vascular Institute in Cleveland, The University of Chicago Hospitals Cardiac Center in Chicago and Brigham & Women's Hospital in Boston.
"The PROTECT trial results establish validity of the Organ Care System. Given its relatively recent introduction to the transplant world, we are excited about the results and look forward to seeing what further tests will demonstrate about this innovative system," said Bruce Rosengard, M.D., Director of Cardiac Transplantation at Massachusetts General Hospital and former ISHLT board member.
Analysis of data from studies conducted in the United Kingdom and Australia were presented by Julian Gooi, M.D., Alfred Hospital, Melbourne, Australia, The Potential Impact of Reducing Cold Ischaemic Time on Cardiac Transplant Survival (Abstract 8) during the same Concurrent Session. The analysis concluded that a CIT of less than one hour would result in longer-term survival or an increase in life-years gained (LYG). Overall, the research showed that there were 2.2 LYG per donor heart for the United Kingdom transplant program, and 2.1 LYG per donor heart for the Australian transplant program. Dr. Gooi's presentation demonstrated how reworking the means of transport and developing central procurement and transplant centers could be beneficial to the transplant community.
"These results should alert the transplant community of issues that need immediate attention in order to increase survivorship in transplant patients. The amount of life years gained through better efficiency within the organ transport system is astonishing," continued Dr. Rosengard.
International Society for Heart and Lung Transplantation
Organ Transplant Current Events and Organ Transplant News RSSMultivisceral transplant survival rates improve with new treatment, says Pittsburgh study
Data from the largest single-center experience of adult and pediatric intestinal and multivisceral transplantation show that survival rates have improved with the advent of innovative surgical techniques, novel immunosuppressive protocols and better post-operative management.
Prompt diagnosis of ear infections can improve outcome for organ transplant recipients
Organ transplant recipients benefit significantly when they are monitored and receive prompt diagnosis and treatment for otitis media, a common inner ear infection.
Study Shows Common Pain Cream Could Protect Heart During Attack
New research from the University of Cincinnati shows that a common, over-the-counter pain salve rubbed on the skin during a heart attack could serve as a cardiac-protectant, preventing or reducing damage to the heart while interventions are administered.
McGill/JGH researchers successfully reverse multiple sclerosis in animals
A new experimental treatment for multiple sclerosis (MS) completely reverses the devastating autoimmune disorder in mice, and might work exactly the same way in humans, say researchers at the Jewish General Hospital Lady Davis Institute for Medical Research and McGill University in Montreal.
Is RTA a new potential option for the treatment of hydatid cysts?
Current treatment of cystic echinococcosis is surgery or percutaneous aspiration, injection and reaspiration (PAIR) using hypertonic saline or ethanol.
UNC scientists identify growth factor as possible cancer drug target
To grow and spread, tumors need new blood vessels, a process called angiogenesis.
TV news on organ donation says little about need, how to become a donor
More than 100,000 people in the U.S. are waiting for an organ transplant, and an average of 17 die waiting each day, according to University of Illinois communication professor Brian Quick.
Baffling the body into accepting transplants
An unexpected discovery made by a Sydney scientist has potential to alter the body's response to anything it perceives as not 'self', such as a tissue or organ transplant.
Montana State University researchers find gene that regulates mold's resistance to drugs
Montana State University scientists concerned about lethal mold infections have found a gene that regulates the mold's resistance to drugs.
What a Sleep Study Can Reveal About Fibromyalgia
Research engineers and sleep medicine specialists from two Michigan universities have joined technical and clinical hands to put innovative quantitative analysis, signal-processing technology and computer algorithms to work in the sleep lab.
More Organ Transplant Current Events and Organ Transplant News Articles
 |
Strange Harvest: Organ Transplants, Denatured Bodies, and the Transformed Self by Lesley A. A. Sharp (Author) Strange Harvest illuminates the wondrous yet disquieting medical realm of organ transplantation by drawing on the voices of those most deeply involved: transplant recipients, clinical specialists, and the surviving kin of deceased organ donors. In this rich and deeply engaging ethnographic study, anthropologist Lesley Sharp explores how these parties think about death, loss, and mourning, especially in light of medical taboos surrounding donor anonymity. As Sharp argues, new forms of embodied intimacy arise in response, and the riveting insights gleaned from her interviews, observations, and descriptions of donor memorials and other transplant events expose how patients and donor families make sense of the transfer of body parts from the dead to the living. For instance, all must grapple... |
 |
Organ Transplants: A Survival Guide for the Entire Family (It Happened to Me) by Tina P. Schwartz (Author) Unlike any other book, this one talks to teens and offers practical advice and suggestions for coping with and surviving the situation when their parent has an organ transplant, or when they are personally facing an organ transplant. It covers how to deal with events that happen before, during, and after the surgery. |
 |
Organ Transplants: Making the Most of Your Gift of Life by Robert Finn (Author), Reg Green (Foreword) Over 64,000 people in the US are living in limbo, awaiting an organ transplant. The good news is that transplants are becoming fairly routine surgical procedures and they do work miracles. People who have been ill for years often describe a feeling of being reborn after a transplant. However, those families who have been told that a loved one needs a transplant to live are thrust into a strange and worrying land. Organ Transplants: Making the Most of Your Gift of Life answers the concerns of families in this difficult situation, including: Deciding whether to have a transplant and choosing a transplant team The importance of the screening interview What factors go into determining a match, and what to do while waiting Detailed information on heart and lung, liver, kidney and... |
 |
Organ Transplant: Making a Match Part of the award winning public television series Healthy Body/Healthy Mind. About sixty years ago, successful organ transplants for humans began to show signs of success. Since then, organ transplants have saved millions of lives worldwide. More than 65,000 Americans are waiting for an organ transplant. While each day about 57 Americans receive a transplant, about 13 will die because not enough organs are available. Once a transplant has been completed, preventing the body's rejection of the transplanted organ can be an ongoing challenge. The body's attempt to destroy the transplanted organ; usually occurs in the first year after transplant. Rejection occurs when the body tries to attack a transplanted organ because it reacts to the organ or tissue as a foreign object and produces... |
 |
Organ Transplants (Cutting Edge Medicine) by Carol Ballard (Author) |
 |
Organ Transplant Awareness Ribbon Mouse Pad by MyHeritageWear.com The Organ Transplant Ribbon proudly displayed on a mouse pad. There is no better way to achieve awareness for the meaning of the Organ Transplant Ribbon than to display it on your mouse pad for everyone to see. The mouse pad measures at 9.25 x 7.75, it is machine washable, and the colors will not fade or run. Start gaining awareness today by presenting your Organ Transplant Ribbon mouse pad at work or at home. It is certain to keep your mouse rolling in style all while gaining support and awareness! |
 |
Organ Transplants: The Role of the Family Physician in Donor Recipient Selection and Management (NCME Video 684) Also With: Network For Continuing Medical Education (Primary Contributor), David J. Cohen (Primary Contributor) |
 |
Organ Transplant: Making a Match Directed By: (c) Information Television Network |
 |
Organ Transplant Survivor Kids Light T-Shirt by CafePress |
|
Organ Transplant |
| © 2009 BrightSurf.com |